Use of modern contraceptives in Lagos Nigeria during the COVID-19 pandemic

Wright, Kikelomo Ololade, Wusu, Onipede, Akinyinka, Modupe, Adebayo, Bisola, Adepoju, Funmilade, Bashir, Khadija, Anifowose, Aderinsola, Ezenwanne, Folakemi and Banke-Thomas, Aduragbemi Oluwabusayo ORCID: 0000-0002-4449-0131 (2022) Use of modern contraceptives in Lagos Nigeria during the COVID-19 pandemic. Health Care for Women International, 43 (4). 382 - 397. ISSN 0739-9332

Text (Manuscript_impact_COVID19_FP_Lagos HCWI_Accepted_version) - Accepted Version Download (274kB)

• Author

Abstract

We estimated modern contraceptive prevalence rate (mCPR) and examined predictors of modern contraceptives utilization amongst 1,445 sampled reproductive age women in Lagos (Nigeria’s epicenter) during the devastating COVID-19 pandemic. Estimated mCPR was 30.8%. Women aged 20–29 years were 50% (95%CI:0.37–0.71) less likely to use modern contraceptives during the pandemic than those 30–39 years. Married and divorced women were about three (95%CI:1.37–5.25) and over three (95%CI:1.32–7.79) times more likely to use modern contraceptives compared to single women. Though mCPR has not reduced, sustained contraceptive needs assessment of sometimes obscure sub-populations is required, especially if outbreaks like COVID-19 become our ‘new normal’.

Item Type:	Article
Official URL:	https://www.tandfonline.com/journals/uhcw20
Additional Information:	© 2021 Taylor & Francis Group, LLC.
Divisions:	LSE Health
Subjects:	H Social Sciences > HV Social pathology. Social and public welfare. Criminology R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine > RG Gynecology and obstetrics
Date Deposited:	14 Mar 2022 16:06
Last Modified:	12 Dec 2024 02:54
URI:	http://eprints.lse.ac.uk/id/eprint/114351

Actions (login required)

View Item